Related Experiment Videos
[Radiotherapy in tubal carcinomas]
U Schäfer1, O Micke, R Witteler
1Klinik und Poliklinik für Strahlentherapie--Radioonkologie, Westfälische n Wilhelms-Universität Münster.
Summary
Adjuvant radiotherapy for fallopian tube cancer may improve outcomes, particularly when the whole abdomen is targeted. Limited radiation to the pelvis or para-aortic region may be palliative for recurrent disease.
Area of Science:
- Gynecologic Oncology
- Radiation Oncology
- Surgical Oncology
Context:
- Fallopian tube cancer is a rare gynecologic malignancy with undefined treatment protocols.
- Surgical resection is the primary treatment, but the role of adjuvant radiotherapy is unclear.
Purpose:
- To evaluate the effectiveness of adjuvant radiotherapy in patients with fallopian tube carcinoma.
- To compare treatment outcomes with existing literature.
Summary:
- Nine patients with fallopian tube cancer received adjuvant radiotherapy post-surgery.
- Tumor stages varied (I-III), with complete resection in 5/9 cases.
- Radiation fields included pelvis, para-aortal region, or whole abdomen; doses ranged from 45-50 Gy.
Impact:
- Median survival was 25 months; 6/9 patients recurred abdominally.
- Whole-abdomen radiotherapy appears indicated, except for early-stage, minimally invasive tumors.
- Pelvic or para-aortic irradiation may serve palliative or salvage roles.